• NaV1.1

    Current–voltage relationships in the absence and presence of 50 μM R-(+)-propranolol.

    Wang et al. (2010)

03.11.2016 | External Webinar: Accelerating Ion Channel Characterization and New Drug Candidate Identification

icon sp96   SyncroPatch 384PE (a predecessor model of SyncroPatch 384i)

This webinar will show high-throughput functional annotation of human ion channel variants associated with excitation disorders will be described along with use of the Syncropatch 384PE to measure subtype selective activation of KV7 potassium channels as well as inhibition of voltage gated sodium channels like NaV1.7, NaV1.1, and NaV1.5.
Organisation: Icagen Inc.

Speaker:

Alfred George, M.D.
Chair, Department of Pharmacology, Northwestern University Feinberg School of Medicine

Matt Fuller, Ph.D.
Senior Scientist, Icagen

Description:

The ever increasing pressure to accelerate drug development by reducing the time to establish strong biological rational, and implement robust discovery programs while maintaining high data quality, has resulted in the advancement of enabling technologies. In the world of ion channel focused drug discovery, this has involved the development and evolution of high-throughput electrophysiology platforms that maintain the high fidelity of the gold-standard patch clamp platform while greatly increasing throughput. This webinar will focus on the application of Nanion Syncropatch 384PE automated electrophysiology platform to enable better understanding of how human disease associated mutations alter ion channel function, and also facilitate drug candidate characterization. Specifically, high-throughput functional annotation of human ion channel variants associated with excitation disorders will be described along with use of the Syncropatch 384PE to measure subtype selective activation of KV7 potassium channels as well as inhibition of voltage gated sodium channels like NaV1.7, NaV1.1, and NaV1.5.


You Will Learn:

  • Characterization of functional changes in voltage-dependent potassium and sodium channel properties associated with human disease causing mutations
  • Use of SyncroPatch 384PE for identifying and characterizing subtype selective modulators of voltage-gated potassium and sodium channels

Playback

Back to Overview

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.